Literature DB >> 4026606

Familial amyotrophic chorea with acanthocytosis. New clinical and laboratory investigations.

K B Gross, J A Skrivanek, K C Carlson, D M Kaufman.   

Abstract

A 46-year-old man, the son of normal nonconsanguinous parents, had a rare progressive neurological illness that began in midlife and was characterized by seizures, buccolingual dyskinesia, orofacial tics, choreiform movements, areflexia, and neurogenic muscle atrophy. Acanthocytosis was present. The serum creatine kinase level was elevated and normobetalipoproteinemia was noted. A brother had a similar disorder. These clinical and laboratory characteristics are consistent with those of previously reported cases of neuroacanthocytosis, ie, familial amyotrophic chorea with acanthocytosis (FACWA). Features not previously reported in cases of FACWA and noted in our index patient are as follows: an increased level of free sialic acid was detected in the serum; haloperidol administered in high doses decreased the orofacial tics; absence of the McLeod blood group phenotype was noted; and Hispanic-Puerto Rican ancestry was documented.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4026606     DOI: 10.1001/archneur.1985.04210090017005

Source DB:  PubMed          Journal:  Arch Neurol        ISSN: 0003-9942


  4 in total

1.  Amyotrophic choreoacanthocytosis: is it really a very rare disease?

Authors:  S Serra; A Arena; A Xerra; A M Gugliotta; S Galatioto
Journal:  Ital J Neurol Sci       Date:  1986-10

Review 2.  Untangling the Thorns: Advances in the Neuroacanthocytosis Syndromes.

Authors:  Ruth H Walker
Journal:  J Mov Disord       Date:  2015-05-31

3.  Neuroacanthocytosis.

Authors:  Adrian Danek; Benedikt Bader; Ruth H Walker
Journal:  Clinics (Sao Paulo)       Date:  2008-02       Impact factor: 2.365

4.  Clinical and molecular research of neuroacanthocytosis.

Authors:  Lihong Zhang; Suping Wang; Jianwen Lin
Journal:  Neural Regen Res       Date:  2013-03-25       Impact factor: 5.135

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.